Soo Lim

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 64

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes

Journal of diabetes investigation

International journal of molecular sciences

Seoul National University Bundang Hospital

Seoul National University Graduate School of Public Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul National University Bundang Hospital Sep 01 2005

South Korea

Professor :: Internal Medicine

Harvard Medical School Mar 01 2011 - Aug 31 2012

United States

Research fellow :: General Internal Medicine

Education History

Seoul National University Graduate School of Public Health Mar 01 2006 - Feb 28 2009

South Korea

PHD

Seoul National University College of Medicine Mar 01 2004 - Feb 28 2006

South Korea

PHD :: Internal Medicine

Publications

Minji Sohn, Seoungyeon Nam, Michael A Nauck, Soo Lim
Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC medicine 22 (1) (2024)
Joon Ho Moon, Hun Jee Choe, Soo Lim
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. Journal of diabetes investigation (2024)
Nam Hoon Kim, Jun Sung Moon, Eun Young Lee, Ho Chan Cho, Soo Heon Kwak, Soo Lim, Min Kyong Moon, Dong-Lim Kim, Tae Ho Kim, Eunvin Ko, Juneyoung Lee, Sin Gon Kim
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial. Diabetes, obesity & metabolism (2024)
Soo Lim, Seung Hwan Lee, Kyung-Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won, Hyuk-Sang Kwon, Mi Kyung Kim, Jung Hwan Park, In-Kyung Jeong, Sungrae Kim
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes, obesity & metabolism 26 (6) (2024)
Joon Ho Moon, Hun Jee Choe, Soo Lim
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. Journal of diabetes investigation 15 (6) (2024)
Sae Im Jeong, Mu Seong Ban, Jun Gi Hwang, Min-Kyu Park, Soo Lim, Sejoong Kim, Soon Kil Kwon, Yoonjin Kim, Jae Min Cho, Jae Jin Na, Wan Huh, Jae-Young Chung
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes, obesity & metabolism (2024)
Minji Sohn, Soo Lim
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis. International journal of molecular sciences 25 (5) (2024)
Minji Sohn, Seoungyeon Nam, Michael A Nauck, Soo Lim
Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC medicine 22 (1) (2024)
Minji Sohn, Soo Lim
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis. International journal of molecular sciences 25 (5) (2024)
Sae Im Jeong, Mu Seong Ban, Jun Gi Hwang, Min-Kyu Park, Soo Lim, Sejoong Kim, Soon Kil Kwon, Yoonjin Kim, Jae Min Cho, Jae Jin Na, Wan Huh, Jae-Young Chung
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes, obesity & metabolism 26 (7) (2024)
Soo Lim, Seung Hwan Lee, Kyung-Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won, Hyuk-Sang Kwon, Mi Kyung Kim, Jung Hwan Park, In-Kyung Jeong, Sungrae Kim
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes, obesity & metabolism (2024)
Ji Yoon Kim, Sang Man Jin, Kang Hee Sim, Bo Yeon Kim, Jae-Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol Young Park, Sin Gon Kim, Jae Hyeon Kim
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Diabetologia (2024)
Minji Sohn, Seoungyeon Nam, Michael A Nauck, Soo Lim
Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC medicine 22 (1) (2024)
Soo Lim, Seung Hwan Lee, Kyung-Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won, Hyuk-Sang Kwon, Mi Kyung Kim, Jung Hwan Park, In-Kyung Jeong, Sungrae Kim
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes, obesity & metabolism 26 (6) (2024)
Joon Ho Moon, Hun Jee Choe, Soo Lim
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. Journal of diabetes investigation 15 (6) (2024)
Minji Sohn, Soo Lim
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis. International journal of molecular sciences 25 (5) (2024)
Joon Ho Moon, Hun Jee Choe, Soo Lim
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. Journal of diabetes investigation 15 (6) (2024)
Inho Kim, Hyun-Jai Cho, Soo Lim, Seung Hyeok Seok, Hae-Young Lee
Author Correction: Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Experimental & molecular medicine (2024)
Joon Ho Moon, Hun Jee Choe, Soo Lim
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. Journal of diabetes investigation 15 (6) (2024)
Ji Yoon Kim, Sang Man Jin, Kang Hee Sim, Bo Yeon Kim, Jae-Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol Young Park, Sin Gon Kim, Jae Hyeon Kim
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Diabetologia 67 (7) (2024)
Nam Hoon Kim, Jun Sung Moon, Eun Young Lee, Ho Chan Cho, Soo Heon Kwak, Soo Lim, Min Kyong Moon, Dong-Lim Kim, Tae Ho Kim, Eunvin Ko, Juneyoung Lee, Sin Gon Kim
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial. Diabetes, obesity & metabolism 26 (9) (2024)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Seon Mee Kang, Han Mi Yun, Minji Sohn, Soo Lim
Vascular and metabolic effects of ipragliflozin versus sitagliptin in type 2 diabetes treated with sulfonylurea and metformin: IVS study. Diabetes, obesity & metabolism (2023)
Minji Sohn, Juan P Frias, Soo Lim
Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Hun Jee Choe, He Ran Oh, Dawei Bu, Ningyan An, Philipp E Scherer, Zhiqiang An, Soo Lim
Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study. Diabetes, obesity & metabolism (2023)
Inho Kim, Hyun-Jai Cho, Soo Lim, Seung Hyeok Seok, Hae-Young Lee
Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Experimental & molecular medicine (2023)
Jaewon Oh, Wonho Kim, Gee Hee Kim, Hack-Lyoung Kim, Sang-Don Park, Kyung Wan Min, Dongkeun Hyun, Jun Hwa Hong, Soo Lim, Jinho Shin, null null
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors. Advances in therapy (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Yingying Luo, Jun Xia, Zhan Zhao, Yaping Chang, Yong Mong Bee, Khue Thy Nguyen, Soo Lim, Daisuke Yabe, Margaret McGill, Alice Pik-Shan Kong, Siew Pheng Chan, Marisa Deodat, Chaicharn Deerochanawong, Ketut Suastika, Chenchen Xu, Liming Chen, Wei Chen, Xiaoying Li, Weigang Zhao, Xiaomei Yao, Li-Nong Ji
Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis. Journal of diabetes (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Seung Min Chung, Jun Sung Moon, Jun Hwa Hong, In-Chang Hwang, Soo Lim
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: the Gemi-Heart study. Diabetes, obesity & metabolism (2023)
Lee-Ling Lim, Eric S H Lau, Johnny T K Cheung, Siew Pheng Chan, Li-Nong Ji, Soo Lim, Sirinart Sirinvaravong, A G Unnikrishnan, Andrea On Yan Luk, Viviana Cortese, Alexandra Durocher, Juliana Chung Ngor Chan
Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. Diabetes, obesity & metabolism (2022)
Soo Lim, Minji Sohn, Yujin Shin, Eleuterio Ferrannini
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effects. Diabetes, obesity & metabolism 24 (4) (2022)
Minji Sohn, Eun Ju Chun, Soo Lim
Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long-term follow-up of the ESCAPE study. Journal of diabetes 14 (8) (2022)
Hae-Jin Ko, Jin-Wook Kim, Soo Lim
Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting. Journal of obesity & metabolic syndrome 31 (3) (2022)
Jae Hyun Bae, Hun Jee Choe, Michael F Holick, Soo Lim
Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review. Reviews in endocrine & metabolic disorders 23 (3) (2022)
Soo Lim, Jae Hyun Bae, Hyuk-Sang Kwon, Michael A Nauck
Reply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19. Nature reviews. Endocrinology 17 (3) (2021)
Jung Ha Park, Ju Young Kim, Jong Han Choi, Hye Soon Park, Hyun-Young Shin, Jae Min Lee, Jin-Wook Kim, Hae-Jin Ko, Suk Chon, Bu Kyung Kim, Chul Sik Kim, Soo Lim
Effectiveness of liraglutide 3 mg for the treatment of obesity in a real-world setting without intensive lifestyle intervention. International journal of obesity (2005) 45 (4) (2021)
Li-Nong Ji, Xiaolin Dong, Yiming Li, Yufeng Li, Soo Lim, Ming Liu, Zu Ning, Søren Rasmussen, Trine Vang Skjøth, Guoyue Yuan, Freddy G Eliaschewitz
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial. Diabetes, obesity & metabolism 23 (2) (2021)
Jae Hoon Moon, Ji Won Han, Tae Jung Oh, Sung Hee Choi, Soo Lim, Ki Woong Kim, Hak Chul Jang
Effect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapy. Clinical endocrinology 93 (2) (2020)
Dong Hwa Lee, Eun Ju Chun, Ji Hye Moon, Han Mi Yun, Soo Lim
Effect of cilostazol on carotid plaque volume measured by three-dimensional ultrasonography in patients with type 2 diabetes: The FANCY study. Diabetes, obesity & metabolism 22 (12) (2020)
Soo Lim, Jae Hyun Bae, Hyuk-Sang Kwon, Michael A Nauck
COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature reviews. Endocrinology 17 (1) (2020)
Soo Lim, Eu Jeong Ku, Seo Young Lee, Ji Hyun Lee, Jie-Eun Lee, Kyoung Min Kim, Melanie J Davies
Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. BMJ open diabetes research & care 8 (1) (2020)
Soo Lim
Journal of Obesity & Metabolic Syndrome: A Platform for Acquiring and Disseminating the Most Recent Research Findings and Developing Research Concepts about Obesity. Journal of obesity & metabolic syndrome (2020)
Soo Lim
Effects of sodium-glucose cotransporter inhibitors on cardiorenal and metabolic systems: Latest perspectives from the outcome trials. Diabetes, obesity & metabolism (2020)
Sang-Man Jin, Soo Lim, Hyuk-Sang Kwon, Ie B Park, Kyu J Ahn, Cheol-Young Park, Su K Kwon, Hye S Kim, Seok W Park, Sin Gon Kim, Min Kyong Moon, Eun S Kim, Choon Hee Chung, Kang S Park, Mikyung Kim, Dong J Chung, Chang B Lee, Tae H Kim, Moon-Kyu Lee
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study). Diabetes, obesity & metabolism 22 (9) (2020)
Soo Lim, Hyun Jung Lim, Jean-Pierre Després
Collateral Damage of the COVID-19 Pandemic on Nutritional Quality and Physical Activity: Perspective from South Korea. Obesity (Silver Spring, Md.) 28 (10) (2020)
Sin Gon Kim, Kyoung Jin Kim, Kun-Ho Yoon, Sung Wan Chun, Kyong Soo Park, Kyung Mook Choi, Soo Lim, Ji-Oh Mok, Hyoung Woo Lee, Ji A Seo, Bong Soo Cha, Mi Kyung Kim, Ho Sang Shon, Dong Seop Choi, Doo-Man Kim
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks. Diabetes, obesity & metabolism 22 (10) (2020)
Hyo Jin Maeng, Gha Young Lee, Jae Hyun Bae, Soo Lim
Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model. International journal of molecular sciences 21 (18) (2020)
Dong-Hwa Lee, Eun Ju Chun, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Kyong Soo Park, Hak Chul Jang, Soo Lim
Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study. Diabetes, obesity & metabolism 21 (6) (2019)
Soo Lim, Tae Jung Oh, Jesse Dawson, Naveed Sattar
Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes, obesity & metabolism 22 (1) (2019)
Kyoung Min Kim, Kyong Yeun Jung, Han Mi Yun, Seo Young Lee, Tae Jung Oh, Hak Chul Jang, Soo Lim
Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovascular diabetology 18 (1) (2019)
Sehyun Chae, Su-Jin Kim, Young Do Koo, Jung Hwa Lee, Hokeun Kim, Byung Yong Ahn, Yong-Chan Ha, Yong-Hak Kim, Mi Gyeong Jang, Kyung-Hoi Koo, Sung Hee Choi, Soo Lim, Young Joo Park, Hak Chul Jang, Daehee Hwang, Sang-Won Lee, Kyong-Soo Park
A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles. Experimental & molecular medicine 50 (9) (2018)
Soo Lim, Marja-Riitta Taskinen, Jan Borén
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity reviews : an official journal of the International Association for the Study of Obesity 20 (4) (2018)
Soo Heon Kwak, Jeesoo Chae, Seungbok Lee, Sungkyoung Choi, Bo Kyung Koo, Ji Won Yoon, Jin-Ho Park, Belong Cho, Min Kyong Moon, Soo Lim, Young Min Cho, Sanghoon Moon, Young Jin Kim, Sohee Han, Mi Yeong Hwang, Yoon Shin Cho, Myung-Shik Lee, Hak Chul Jang, Hyun Min Kang, Taesung Park, Nam H Cho, Kyunga Kim, Jong-Il Kim, Kyong-Soo Park
Nonsynonymous Variants in PAX4 and GLP1R Are Associated With Type 2 Diabetes in an East Asian Population. Diabetes 67 (9) (2018)
Eun Roh, Kyoung M Kim, Kyeong S Park, Yoon J Kim, Eun J Chun, Sung H Choi, Kyong S Park, Hak C Jang, Soo Lim
Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans. Diabetes, obesity & metabolism 20 (11) (2018)
Kyung-Ah Han, Suk Chon, Choon Hee Chung, Soo Lim, Kwan-Woo Lee, SeiHyun Baik, Chang Hee Jung, Dong-Sun Kim, Kyong Soo Park, Kun-Ho Yoon, In-Kyu Lee, Bong Soo Cha, Taishi Sakatani, Sumi Park, Moon Kyu Lee
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial. Diabetes, obesity & metabolism 20 (10) (2018)
Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Bo Kyung Koo, Min Kyong Moon, Soo Lim, Hak Chul Jang, Kyong-Soo Park, Young Min Cho
The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes care 42 (1) (2018)
Jie Eun Lee, Dong Hwa Lee, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang, Jae Hoon Moon
Clinical Feasibility of Monitoring Resting Heart Rate Using a Wearable Activity Tracker in Patients With Thyrotoxicosis: Prospective Longitudinal Observational Study. JMIR mHealth and uHealth 6 (7) (2018)
Jie Eun Lee, Dong Hwa Lee, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang, Jae Hoon Moon
Clinical Feasibility of Continuously Monitored Data for Heart Rate, Physical Activity, and Sleeping by Wearable Activity Trackers in Patients with Thyrotoxicosis: Protocol for a Prospective Longitudinal Observational Study. JMIR research protocols 7 (2) (2018)
Kyoung Min Kim, Kyong Yeun Jung, Han Mi Yun, Seo Young Lee, Tae Jung Oh, Hak Chul Jang, Soo Lim
Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovascular diabetology 16 (1) (2017)
Young Shin Song, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang, Kyong Soo Park, Soo Lim
Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012. Diabetes & metabolism journal 41 (1) (2016)

Soo Lim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Soo Lim